FDA — authorised 13 March 2003
- Application: NDA021481
- Marketing authorisation holder: ROCHE
- Local brand name: FUZEON
- Indication: INJECTABLE — SUBCUTANEOUS
- Status: approved
🇺🇸 Fuzeon in United States
FDA authorised Fuzeon on 13 March 2003
Marketing authorisation
Other Immunology approved in United States
Frequently asked questions
Is Fuzeon approved in United States?
Yes. FDA authorised it on 13 March 2003.
Who is the marketing authorisation holder for Fuzeon in United States?
ROCHE holds the US marketing authorisation.